Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
Acq. announced
Director departure
Adhera Therapeutics, Inc. (ATRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2018 8-K Resignation/termination of a director, Appointed a new director
Docs: "Omnibus Settlement Agreement, by and among Marina Biotech, Inc., Vuong Trieu, Ph.D., Autotelic Inc., Autotelic LLC, Autotelic BIO, Oncotelic, Inc. and LipoMedics, Inc",
"Marina Biotech Appoints Nancy R. Phelan to the Board of Directors Research Triangle Park, NC – October 3, 2018 – Marina Biotech, Inc. , a commercial stage pharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis and pain, today announced that Nancy R. Phelan has been appointed to serve as a member of its Board of Directors, effective today."
12/14/2016 8-K Form 8-K - Current report
11/18/2016 8-K Form 8-K - Current report
09/08/2011 8-K Appointed a new director
Docs: "EMPLOYMENT AGREEMENT, EFFECTIVE SEPTEMBER 1, 2011",
"AMENDMENT NO. 1, EFFECTIVE SEPTEMBER 1, 2011",
"EMPLOYMENT AGREEMENT, EFFECTIVE SEPTEMBER 7, 2011",
"Marina Biotech Announces Organizational Changes Appoints Richard T. Ho, M.D., Ph.D. to newly created position of Executive Vice President, Research and Development; Names Philip C. Ranker as Interim Chief Financial Officer; Barry Polisky, Ph.D. transitions from Chief Scientific Officer to Distinguished Scientist and Chair of the Company's Scientific Advisory Panel; Michael V. Templin, Ph.D. is promoted to newly created position of Senior Vice President and Chief Technology Officer; Alan W. Dunton, M.D. joins the Company as consulting Chief Medical Officer"
07/23/2010 8-K Form 8-K - Current report
06/13/2008 8-K Appointed a new director
Docs: "Certificate of Amendment of the Amended and Restated Certificate of Incorporation of MDRNA, Inc.",
"Amended Designation, Rights and Preferences of Series A Junior Participating Preferred Stock",
"Employment Agreement between the Company and Dr. Steven C. Quay",
"Employment Agreement between the Company and J. Michael French",
"Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer"
09/25/2007 8-K Appointed a new director
Docs: "Amended and Restated By-Laws of the Company"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy